To conduct a more in‐depth examination of the potential mechanisms that influence survival differences, our initial investigation involved comparing genes that exhibit high rates of somatic mutations in esophageal cancers, such as TP53, TTN, and MUC16. This evidence concerns the gene TTN and esophageal cancer.